Chen Wenqing, Qi Jianzhao, Wu Pan, Wan Dan, Liu Jin, Feng Xuan, Deng Zixin
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, and School of Pharmaceutical Sciences, Wuhan university, Wuhan, 430071, China.
State Key Laboratory of Microbial Metabolism, and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200030, China.
J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):401-17. doi: 10.1007/s10295-015-1636-3. Epub 2015 Jul 8.
Nucleoside antibiotics constitute an important family of microbial natural products bearing diverse bioactivities and unusual structural features. Their biosynthetic logics are unique with involvement of complex multi-enzymatic reactions leading to the intricate molecules from simple building blocks. Understanding how nature builds this family of antibiotics in post-genomic era sets the stage for rational enhancement of their production, and also paves the way for targeted persuasion of the cell factories to make artificial designer nucleoside drugs and leads via synthetic biology approaches. In this review, we discuss the recent progress and perspectives on the natural and engineered biosynthesis of nucleoside antibiotics.
核苷类抗生素是一类重要的微生物天然产物,具有多样的生物活性和独特的结构特征。它们的生物合成逻辑独特,涉及复杂的多酶反应,能将简单的构建单元转化为复杂的分子。在后基因组时代,了解自然界如何合成这类抗生素,为合理提高其产量奠定了基础,也为通过合成生物学方法有针对性地诱导细胞工厂生产人工设计的核苷类药物及先导化合物铺平了道路。在本综述中,我们讨论了核苷类抗生素天然和工程生物合成的最新进展及前景。